Frédéric Picard‐Jean

569 total citations
12 papers, 435 citations indexed

About

Frédéric Picard‐Jean is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Frédéric Picard‐Jean has authored 12 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Frédéric Picard‐Jean's work include RNA modifications and cancer (4 papers), RNA and protein synthesis mechanisms (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Frédéric Picard‐Jean is often cited by papers focused on RNA modifications and cancer (4 papers), RNA and protein synthesis mechanisms (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Frédéric Picard‐Jean collaborates with scholars based in Canada, United States and United Kingdom. Frédéric Picard‐Jean's co-authors include Martin Bisaillon, Isabelle Bougie, Brian J. Geiss, Sarah E. Hobdey, Daniel A. Lafontaine, Adrien Chauvier, Laurène Bastet, Jonathan Perreault, Andréa Allaire and Jerry Pelletier and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Frédéric Picard‐Jean

12 papers receiving 431 citations

Peers

Frédéric Picard‐Jean
Jianlin Fu Singapore
Frédéric Picard‐Jean
Citations per year, relative to Frédéric Picard‐Jean Frédéric Picard‐Jean (= 1×) peers Jianlin Fu

Countries citing papers authored by Frédéric Picard‐Jean

Since Specialization
Citations

This map shows the geographic impact of Frédéric Picard‐Jean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Picard‐Jean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Picard‐Jean more than expected).

Fields of papers citing papers by Frédéric Picard‐Jean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Picard‐Jean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Picard‐Jean. The network helps show where Frédéric Picard‐Jean may publish in the future.

Co-authorship network of co-authors of Frédéric Picard‐Jean

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Picard‐Jean. A scholar is included among the top collaborators of Frédéric Picard‐Jean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Picard‐Jean. Frédéric Picard‐Jean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
St-Pierre, Patrick, et al.. (2021). A structural intermediate pre-organizes the add adenine riboswitch for ligand recognition. Nucleic Acids Research. 49(10). 5891–5904. 11 indexed citations
2.
Picard‐Jean, Frédéric, Andréa Allaire, Simon Boudreault, et al.. (2018). 2'-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO. PLoS ONE. 13(3). e0193804–e0193804. 53 indexed citations
3.
Chauvier, Adrien, et al.. (2017). Transcriptional pausing at the translation start site operates as a critical checkpoint for riboswitch regulation. Nature Communications. 8(1). 13892–13892. 69 indexed citations
4.
Picard‐Jean, Frédéric, et al.. (2017). Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile. European Journal of Medicinal Chemistry. 143. 755–768. 28 indexed citations
5.
Allaire, Andréa, Frédéric Picard‐Jean, & Martin Bisaillon. (2015). Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus. Journal of Visualized Experiments. 6 indexed citations
6.
Allaire, Andréa, Frédéric Picard‐Jean, & Martin Bisaillon. (2015). Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus. Journal of Visualized Experiments. 3 indexed citations
7.
Picard‐Jean, Frédéric, et al.. (2014). The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein. Antiviral Research. 111. 13–22. 18 indexed citations
8.
Picard‐Jean, Frédéric, Isabelle Bougie, Satoshi Shuto, & Martin Bisaillon. (2013). The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme. PLoS ONE. 8(1). e54621–e54621. 7 indexed citations
9.
Picard‐Jean, Frédéric, et al.. (2010). The RNA capping machinery as an anti‐infective target. Wiley Interdisciplinary Reviews - RNA. 2(2). 184–192. 14 indexed citations
10.
11.
Picard‐Jean, Frédéric, Isabelle Bougie, & Martin Bisaillon. (2007). Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54. Biochemical Journal. 407(3). 331–341. 13 indexed citations
12.
Bougie, Isabelle, et al.. (2006). Energetics of RNA binding by the West Nile virus RNA triphosphatase. FEBS Letters. 580(3). 867–877. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026